HealthDay - TUESDAY, July 15 (HealthDay News) -- An in-trial dendritic cell vaccine
that fights malignant brain tumors called glioblastoma multiforme (GBM)
may help boost a patient's immunity response and improve the outcome, a
new report says.
<a href=http://us.rd.yahoo.com/dailynews/rss/cancer/*http://news.yahoo.com/s/hsn/20080716/hl_hsn/braincancervaccinesimmuneresponsekeytooutcomestarget=_blank>Read more...